Detalles de la búsqueda
1.
Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective.
Blood Adv
; 8(5): 1200-1208, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38055922
2.
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
Adv Ther
; 41(4): 1637-1651, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38427220
3.
Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies: Secondary Analysis from a Pivotal Phase 3 Clinical Trial.
Transplant Cell Ther
; 29(12): 749.e1-749.e5, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37703995
4.
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
Transplant Cell Ther
; 29(1): 52.e1-52.e9, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179986
5.
Correction to: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies.
Adv Ther
; 2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762585
Resultados
1 -
5
de 5
1
Próxima >
>>